Hillary Tompkins, MD
Gastroenterology · Exeter, NHNPI 1093836157
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $19,493 of the $20,590 with a category attached, or 94.7%. Takeda Pharmaceuticals U.S.A., Inc. accounts for 99.0% of it on its own, with 3 other manufacturers making up the rest. 2025 is the largest year on record at $19,158, more than ten times the $144 reported in 2019. Among gastroenterology clinicians in NH with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 24 payments — averaging $857.93 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Takeda Pharmaceuticals U.S.A., Inc.$20K
- Boston Scientific$74
- Cook Medical LLC$71
- AbbVie$60
Across 1 payment — averaging $4537.50 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Braintree Laboratories, Inc.$5K
What the payments were for
- Speaking & faculty fees$19,49395%
- Travel & lodging$2671%
- Food & beverage$8314%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | 19 | $20,386 |
| Boston Scientific | 2 | $74 |
| Cook Medical LLC | 1 | $71 |
| AbbVie | 2 | $60 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Entyvio$19,955
How this compares
$20,590 in reported general payments places this provider in the 90th percentile of 91 gastroenterology providers in New Hampshire.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Humira PenAdalimumab | 13 | $83,907 |
| XifaxanRifaximin | 11 | $30,804 |
| Budesonide EcBudesonide | 11 | $12,399 |
| Gavilyte-GPeg3350/Sod Sulf,bicarb,cl/Kcl | 402 | $4,999 |
| Peg-3350 And ElectrolytesPeg3350/Sod Sulf,bicarb,cl/Kcl | 200 | $2,708 |
| PlenvuPeg3350/Sod Sul/Nacl/Kcl/Asb/C | 16 | $2,265 |
| Gavilyte-CPeg3350/Sod Sulf,bicarb,cl/Kcl | 137 | $1,908 |
| Balsalazide Disodium | 13 | $1,504 |
| Mesalamine | 17 | $1,375 |
| Sod Sulf-Potass Sulf-Mag SulfSodium, Potassium,mag Sulfates | 12 | $636 |
| Azathioprine | 17 | $508 |
| Peg 3350-ElectrolyteSodium Chloride/Nahco3/Kcl/Peg | 18 | $480 |
| Omeprazole | 24 | $429 |
| Dicyclomine Hcl | 15 | $251 |
| Famotidine | 35 | $207 |
Paid to pharmacies, not to this prescriber.
Other gastroenterology in Exeter
- Thomas LiuExeter$2K
- Lee KaplanLebanon$1.2M
- Corey SiegelLebanon$602K
- Brian LacyLebanon$177K
- Leon McLeanDerry$171K
- Shelby SullivanLebanon$137K
- Michael WinterLebanon$58K
- Stuart GordonLebanon$42K
- Robert RubenSomersworth$36K
- Timothy GardnerLebanon$17K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.